Shared and dissociable features of apathy and reward system dysfunction in bipolar i disorder and schizophrenia

Psychological Medicine

Volumn 50, Issue 6, 2020, Pages 936-947

  Kirschner, Matthias ^a,b   Cathomas, Flurin ^a   Manoliu, Andrei ^a,c   Habermeyer, Benedikt ^d   Simon, Joe J ^e,f   Seifritz, Erich ^a,g   Tobler, Philippe N ^g   Kaiser, Stefan ^h  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Psychiatric Health Care Aargau   (Switzerland)

^e Centre for Psychosocial Medicine   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY OF ZURICH   (Switzerland)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Apathy; bipolar disorder; diminished expression; euthymic; fMRI; Monetary Incentive Delay Task; negative symptoms; reward anticipation; striatum; transdiagnostic

Indexed keywords

ADULT; APATHY; BIPOLAR DISORDER; BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; DISSOCIATIVE DISORDER; FEMALE; HUMAN; MALE; MIDDLE AGED; MOTIVATION; NEOSTRIATUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOLOGY; REWARD; SCHIZOPHRENIA; VENTRAL STRIATUM; YOUNG ADULT;

ADULT; APATHY; BIPOLAR DISORDER; BRAIN; BRAIN MAPPING; DISSOCIATIVE DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTIVATION; NEOSTRIATUM; PREFRONTAL CORTEX; REWARD; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VENTRAL STRIATUM; YOUNG ADULT;

EID: 85064995792     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291719000801     Document Type: Article

References (79)

1. Ackenheil M, Stotz G and Dietz-Bauer R (1999) Mini International Neuropsychiatric Interview. German Version 5.0.0, DSM-IV. München: Psychiatrische Universitätsklinik München.
2. Addington D, Addington J and Schissel B (1990) A depression rating scale for schizophrenics. Schizophrenia Research 3, 247-251.
3. American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC.
4. Arrondo G, Segarra N, Metastasio A, Ziauddeen H, Spencer J, Reinders NR, Dudas RB, Robbins TW, Fletcher PC and Murray GK (2015) Reduction in ventral striatal activity when anticipating a reward in depression and schizophrenia: a replicated cross-diagnostic finding. Frontiers in Psychology 6, 1280.
5. Ashok AH, Marques TR, Jauhar S, Nour MM, Goodwin GM, Young AH and Howes OD (2017) The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Molecular Psychiatry 22, 666-679.
6. Atre-Vaidya N, Taylor MA, Seidenberg M, Reed R, Perrine A and Glick-Oberwise F (1998) Cognitive deficits, psychopathology, and psycho-social functioning in bipolar mood disorder. Cognitive and Behavioral Neurology 11, 120-126.
7. Barch DM and Dowd EC (2010) Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophrenia Bulletin 36, 919-934.
8. Blanchard JJ and Cohen AS (2006) The structure of negative symptoms within schizophrenia: implications for assessment. Schizophrenia Bulletin 32, 238-245.
9. Bonnin CM, Martinez-Aran A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J and Vieta E (2010) Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. Journal of Affective Disorders 121, 156-160.
10. Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, Clark L, Cubukcuoglu Z, Dias VV, Dittmann S, Ferrier IN, Fleck DE, Frangou S, Gallagher P, Jones L, Kieseppa T, Martinez-Aran A, Melle I, Moore PB, Mur M, Pfennig A, Raust A, Senturk V, Simonsen C, Smith DJ, Bio DS, Soeiro-de-Souza MG, Stoddart SD, Sundet K, Szoke A, Thompson JM, Torrent C, Zalla T, Craddock N, Andreassen OA, Leboyer M, Vieta E, Bauer M, Worhunsky PD, Tzagarakis C, Rogers RD, Geddes JR and Goodwin GM (2013) Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatrica Scandinavica 128, 149-162.
11. Caravaggio F, Fervaha G, Menon M, Remington G, Graff-Guerrero A and Gerretsen P (2018) The neural correlates of apathy in schizophrenia: an exploratory investigation. Neuropsychologia 118, 34-39.
12. Caseras X, Lawrence NS, Murphy K, Wise RG and Phillips ML (2013) Ventral striatum activity in response to reward: differences between bipolar I and II disorders. American Journal of Psychiatry 170, 533-541.
13. Cathomas F, Hartmann MN, Seifritz E, Pryce CR and Kaiser S (2015) The translational study of apathy-an ecological approach. Frontiers in Behavioral Neuroscience 9, 241.
14. Cools R, Blackwell A, Clark L, Menzies L, Cox S and Robbins TW (2005) Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology 30, 1362-1373.
15. Cuthbert BN and Insel TR (2010) Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophrenia Bulletin 36, 1061-1062.
16. Cuthbert BN and Insel TR (2013) Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Medicine 11, 126.
17. Di Nicola M, De Risio L, Battaglia C, Camardese G, Tedeschi D, Mazza M, Martinotti G, Pozzi G, Niolu C, Di Giannantonio M, Siracusano A and Janiri L (2013) Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature? Journal of Affective Disorders 147, 446-450.
18. Dias VV, Brissos S, Frey BN and Kapczinski F (2008) Insight, quality of life and cognitive functioning in euthymic patients with bipolar disorder. Journal of Affective Disorders 110, 75-83.
19. Dowd EC, Frank MJ, Collins A, Gold JM and Barch DM (2016) Probabilistic reinforcement learning in patients with schizophrenia: relationships to anhedonia and avolition. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 1, 460-473.
20. Dutra SJ, Cunningham WA, Kober H and Gruber J (2015) Elevated striatal reactivity across monetary and social rewards in bipolar I disorder. Journal of Abnormal Psychology 124, 890-904.
21. Frances A, Pincus HA and First MB (1994) The Global Assessment of Functioning Scale (GAF). Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association.
22. Galderisi S, Mucci A, Buchanan RW and Arango C (2018) Negative symptoms of schizophrenia: new developments and unanswered research questions. The Lancet. Psychiatry 5, 664-677.
23. Hagele C, Schlagenhauf F, Rapp M, Sterzer P, Beck A, Bermpohl F, Stoy M, Strohle A, Wittchen HU, Dolan RJ and Heinz A (2015) Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders. Psychopharmacology 232, 331-341.
24. Hager OM, Kirschner M, Bischof M, Hartmann-Riemer MN, Kluge A, Seifritz E, Tobler PN and Kaiser S (2015) Reward-dependent modulation of working memory is associated with negative symptoms in schizophrenia. Schizophrenia Research 168, 238-244.
25. Hamilton M (1967) Development of a rating scale for primary depressive illness. British Journal of Clinical Psychology 6, 278-296.
26. Hartmann MN, Hager OM, Reimann AV, Chumbley JR, Kirschner M, Seifritz E, Tobler PN and Kaiser S (2015) Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort. Schizophrenia Bulletin 41, 503-512.
27. Hawkins KA, Hoffman RE, Quinlan DM, Rakfeldt J, Docherty NM and Sledge WH (1997) Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar, and control samples. The Journal of Neuropsychiatry and Clinical Neurosciences 9, 81-89.
28. Heinz A and Schlagenhauf F (2010) Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophrenia Bulletin 36, 472-485.
29. Husai M and Roiser JP (2018) Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nature Review Neuroscience 19, 470-484.
30. Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Turkheimer F, McGuire P, Young AH and Howes OD (2017) A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry 74, 1206-1213.
31. Juckel G, Schaub D, Fuchs N, Naumann U, Uhl I, Witthaus H, Hargarter L, Bierhoff HW and Brune M (2008) Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia. Schizophrenia Research 104, 287-293.
32. Kay SR, Opler LA and Lindenmayer JP (1989) The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. The British Journal of Psychiatry, 59-67.
33. Kaiser S, Lyne J, Agartz I, Clarke M, Morch-Johnsen L and Faerden A (2017) Individual negative symptoms and domains-relevance for assessment, pathomechanisms and treatment. Schizophrenia Research 186, 39-45.
34. Kirkpatrick B (2014) Developing concepts in negative symptoms: primary vs secondary and apathy vs expression. Journal of Clinical Psychiatry 75(suppl. 1), 3-7.
35. Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A and Marder SR (2011) The brief negative symptom scale: psychometric properties. Schizophrenia Bulletin 37, 300-305.
36. Kirschner M, Hager OM, Bischof M, Hartmann-Riemer MN, Kluge A, Seifritz E, Tobler PN and Kaiser S (2016a) Deficits in context-dependent adaptive coding of reward in schizophrenia. NPJ Schizophrenia 2, 16020.
37. Kirschner M, Hager OM, Bischof M, Hartmann MN, Kluge A, Seifritz E, Tobler PN and Kaiser S (2016b) Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia. Journal of Psychiatry and Neuroscience 41, 152-161.
38. Kirschner M, Aleman A and Kaiser S (2017) Secondary negative symptoms-a review of mechanisms, assessment and treatment. Schizophrenia Research 186, 29-38.
39. Kirschner M, Hager OM, Muff L, Bischof M, Hartmann-Riemer MN, Kluge A, Habermeyer B, Seifritz E, Tobler PN and Kaiser S (2018) Ventral striatal dysfunction and symptom expression in individuals with schizotypal personality traits and early psychosis. Schizophrenia Bulletin 44, 147-157.
40. Kluge A, Kirschner M, Hager OM, Bischof M, Habermeyer B, Seifritz E, Walther S and Kaiser S (2018) Combining actigraphy, ecological momentary assessment and neuroimaging to study apathy in patients with schizophrenia. Schizophrenia Research 195, 176-182.
41. Knutson B and Greer SM (2008) Anticipatory affect: neural correlates and consequences for choice. Philosophical Transactions of the Royal Society B: Biological Sciences 363, 3771-3786.
42. Knutson B, Westdorp A, Kaiser E and Hommer D (2000) FMRI visualization of brain activity during a monetary incentive delay task. Neuroimage 12, 20-27.
43. Kraepelin E (1921) Dementia praecox and paraphrenia. The Journal of Nervous and Mental Disease 54, 384.
44. Maldjian JA, Laurienti PJ, Kraft RA and Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19, 1233-1239.
45. Mancuso SG, Morgan VA, Mitchell PB, Berk M, Young A and Castle DJ (2015) A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the Second Australian national psychosis survey. Journal of Affective Disorders 172, 30-37.
46. Mason L, O'Sullivan N, Montaldi D, Bentall RP and El-Deredy W (2014) Decision-making and trait impulsivity in bipolar disorder are associated with reduced prefrontal regulation of striatal reward valuation. Brain 137, 2346-2355.
47. Micoulaud-Franchi JA, Faugere M, Weibel S, Faget C, Lancon C, Richieri R and Cermolacce M (2018) Toward a transdiagnostic tool to evaluate depressive symptoms across mental disorders: validation of the Calgary depression rating scale in patients with major depressive disorder. Psychiatry Research 268, 68-71.
48. Mucci A, Dima D, Soricelli A, Volpe U, Bucci P, Frangou S, Prinster A, Salvatore M, Galderisi S and Maj M (2015) Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback. Psychological Medicine 45, 1765-1778.
49. Nielsen MO, Rostrup E, Wulff S, Bak N, Lublin H, Kapur S and Glenthoj B (2012) Alterations of the brain reward system in antipsychotic naive schizophrenia patients. Biological Psychiatry 71, 898-905.
50. Nielsen MØ, Rostrup E, Broberg BV, Wulff S and Glenthøj B (2018) Negative symptoms and reward disturbances in schizophrenia before and after antipsychotic monotherapy. Clinical EEG and Neuroscience 49, 36-45.
51. Nusslock R, Almeida JR, Forbes EE, Versace A, Frank E, Labarbara EJ, Klein CR and Phillips ML (2012) Waiting to win: elevated striatal and orbitofrontal cortical activity during reward anticipation in euthymic bipolar disorder adults. Bipolar Disorder 14, 249-260.
52. Phillips ML, Travis MJ, Fagiolini A and Kupfer DJ (2008) Medication effects in neuroimaging studies of bipolar disorder. American Journal of Psychiatry 165, 313-320.
53. Pizzagalli DA, Goetz E, Ostacher M, Iosifescu DV and Perlis RH (2008) Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task. Biological Psychiatry 64, 162-168.
54. Radua J, Schmidt A, Borgwardt S, Heinz A, Schlagenhauf F, McGuire P and Fusar-Poli P (2015) Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis. JAMA Psychiatry 72, 1243-1251.
55. Redlich R, Dohm K, Grotegerd D, Opel N, Zwitserlood P, Heindel W, Arolt V, Kugel H and Dannlowski U (2015) Reward processing in unipolar and bipolar depression: a functional MRI study. Neuropsychopharmacology 40, 2623-2631.
56. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN and Moore PB (2006) A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. Journal of Affective Disorders 93, 105-115.
57. Roux P, Raust A, Cannavo AS, Aubin V, Aouizerate B, Azorin JM, Bellivier F, Belzeaux R, Bougerol T, Cussac I, Courtet P, Etain B, Gard S, Job S, Kahn JP, Leboyer M, Olie E, Henry C and Passerieux C (2017) Associations between residual depressive symptoms, cognition, and functioning in patients with euthymic bipolar disorder: results from the FACE-BD cohort. British Journal of Psychiatry 211, 381-387.
58. Samalin L, Reinares M, de Chazeron I, Torrent C, Bonnin CM, Hidalgo-Mazzei D, Murru A, Pacchiarotti I, Geoffroy PA, Bellivier F, Llorca PM and Vieta E (2016) Course of residual symptoms according to the duration of euthymia in remitted bipolar patients. Acta Psychiatrica Scandinavica 134, 57-64.
59. Satterthwaite TD, Kable JW, Vandekar L, Katchmar N, Bassett DS, Baldassano CF, Ruparel K, Elliott MA, Sheline YI, Gur RC, Gur RE, Davatzikos C, Leibenluft E, Thase ME and Wolf DH (2015) Common and dissociable dysfunction of the reward system in bipolar and unipolar depression. Neuropsychopharmacology 40, 2258-2268.
60. Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J and Heinz A (2008) Reward system activation in schizophrenic patients switched from typical neuroleptics to olanza-pine. Psychopharmacology 196, 673-684.
61. Serafini G, Vazquez GH, Gonda X, Pompili M, Rihmer Z and Amore M (2018) Depressive residual symptoms are associated with illness course characteristics in a sample of outpatients with bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience 268, 757-768.
62. Sescousse G, Caldu X, Segura B and Dreher JC (2013) Processing of primary and secondary rewards: a quantitative meta-analysis and review of human functional neuroimaging studies. Neuroscience and Biobehavioral Reviews 37, 681-696.
63. Simon JJ, Biller A, Walther S, Roesch-Ely D, Stippich C, Weisbrod M and Kaiser S (2010) Neural correlates of reward processing in schizophrenia-relationship to apathy and depression. Schizophrenia Research 118, 154-161.
64. Simon JJ, Cordeiro SA, Weber MA, Friederich HC, Wolf RC, Weisbrod M and Kaiser S (2015) Reward system dysfunction as a neural substrate of symptom expression across the general population and patients with schizophrenia. Schizophrenia Bulletin 41, 1370-1378.
65. Simpson GM and Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 212, 11-19.
66. Steiger JH (1980) Tests for comparing elements of a correlation matrix. Psychological Bulletin 87, 245-251.
67. Stepien M, Manoliu A, Kubli R, Schneider K, Tobler PN, Seifritz E, Herdener M, Kaiser S and Kirschner M (2018) Investigating the association of ventral and dorsal striatal dysfunction during reward anticipation with negative symptoms in patients with schizophrenia and healthy individuals. PLoS ONE 13, e0198215.
68. Strauss GP and Cohen AS (2017) A transdiagnostic review of negative symptom phenomenology and etiology. Schizophrenia Bulletin 43, 712-719.
69. Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF and Carpenter Jr WT (2013) Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research 47, 783-790.
70. Strauss GP, Vertinski M, Vogel SJ, Ringdahl EN and Allen DN (2016) Negative symptoms in bipolar disorder and schizophrenia: a psychometric evaluation of the brief negative symptom scale across diagnostic categories. Schizophrenia Research 170, 285-289.
71. Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S and Berk M (2009) The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disorders 11, 453-473.
72. Trost S, Diekhof EK, Zvonik K, Lewandowski M, Usher J, Keil M, Zilles D, Falkai P, Dechent P and Gruber O (2014) Disturbed anterior prefrontal control of the mesolimbic reward system and increased impulsivity in bipolar disorder. Neuropsychopharmacology 39, 1914-1923.
73. Tso IF, Grove TB and Taylor SF (2014) Differential hedonic experience and behavioral activation in schizophrenia and bipolar disorder. Psychiatry Research 219, 470-476.
74. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope III CA, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ, AlMazroa MA and Memish ZA (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163-2196.
75. Wallwork RS, Fortgang R, Hashimoto R, Weinberger DR and Dickinson D (2012) Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophrenia Research 137, 246-250.
76. Wang Y, Liu WH, Li Z, Wei XH, Jiang XQ, Geng FL, Zou LQ, Lui SS, Cheung EF, Pantelis C and Chan RC (2016) Altered corticostriatal functional connectivity in individuals with high social anhedonia. Psychological Medicine 46, 125-135.
77. Wolf DH, Satterthwaite TD, Kantrowitz JJ, Katchmar N, Vandekar L, Elliott MA and Ruparel K (2014) Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophrenia Bulletin 40, 1328-1337.
78. Yip SW, Worhunsky PD, Rogers RD and Goodwin GM (2015) Hypoactivation of the ventral and dorsal striatum during reward and loss anticipation in antipsychotic and mood stabilizer-naive bipolar disorder. Neuropsychopharmacology 40, 658-666.
79. Young RC, Biggs JT, Ziegler VE and Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133, 429-435.